Company
Last deal
$151.4M
Local Amount - CNY 1.1B
Amount
Series C
Stage
30.06.2023
Date
3
all rounds
$239.7M
Total amount
General
About Company
Worg Pharmaceuticals is developing new treatments for allergy and other diseases with high unmet medical needs and commercial potential.
Industry
Sector :
Subsector :
Keywords :
Also Known As
百明信康, 百明信康生物技术(杭州)有限公司
founded date
01.01.2018
Number of employees
Last funding type
Series C
IPO status
Private
Contacts
location
Phone number
Website URL